BiotechTube
Home/Pipeline/TRWR‑T2D

TRWR‑T2D

Type 2 Diabetes

Phase 2Active

Key Facts

Indication
Type 2 Diabetes
Phase
Phase 2
Status
Active
Company
Taiwan Resonant Waves Research

About Taiwan Resonant Waves Research

TRWR creates wearable bioelectronic devices that use electrical stimulation to treat chronic diseases such as diabetes and sleep disorders.

View full company profile

Therapeutic Areas

MetabolismImmunologyNeurology

Other Type 2 Diabetes Drugs

DrugCompanyPhase
Diabetes Management GelGelteq LimitedFormulation Development
TolimidoneBiodexa PharmaceuticalsPhase 2
Generic Semaglutide Injection (Obeda)Dr. Reddy's LaboratoriesApproved
BioChaperone® LisproAdociaPhase 3
BioChaperone® Combo (Insulin Glargine / Lixisenatide)AdociaPhase 2
Metformin APIUSV Biologics DivisionCommercial
EmpagliflozinAzico BiophoreCommercial
Sitagliptin IntermediateAR Life ScienceCommercial
AJN003 (LuCI™)AltrixBioPre-clinical
Sitagliptin Phosphate PolymorphMorepen LaboratoriesPre‑clinical
Hepatic Denervation for Type 2 DiabetesMetaventionFeasibility
MVD-1 (SANA)Eolo PharmaDiscovery